PHARMACYTE BIOTECH, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/827ea70a-a31c-493b-8e14-915d40c96135/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-19.4M | 2025-05-01 – 2026-04-30 | evidence 0001683168-26-005836 |
| FY 2024 | $30.7M | 2024-05-01 – 2025-04-30 | evidence 0001683168-25-005821 |
| FY 2023 | $333.8k | 2023-05-01 – 2024-04-30 | evidence 0001683168-24-005575 |
| FY 2022 | $-4.3M | 2022-05-01 – 2023-04-30 | evidence 0001683168-23-005175 |
| FY 2021 | $-4.2M | 2021-05-01 – 2022-04-30 | evidence 0001683168-22-005189 |
| FY 2020 | $-3.6M | 2020-05-01 – 2021-04-30 | evidence 0001683168-21-003377 |
| FY 2019 | $-3.8M | 2019-05-01 – 2020-04-30 | evidence 0001683168-20-002680 |
| FY 2018 | $-4.1M | 2018-05-01 – 2019-04-30 | evidence 0001683168-19-002559 |
| FY 2017 | $-6.8M | 2017-05-01 – 2018-04-30 | evidence 0001683168-18-001994 |
| FY 2016 | $-4.4M | 2016-05-01 – 2017-04-30 | evidence 0001683168-17-001881 |
| FY 2015 | $-6.1M | 2015-05-01 – 2016-04-30 | evidence 0001019687-16-007057 |
| FY 2014 | $-9.9M | 2014-05-01 – 2015-04-30 | evidence 0001019687-16-004856 |
| FY 2013 | $-27.3M | 2013-05-01 – 2014-04-30 | evidence 0001019687-14-002942 |
| FY 2012 | $-1.6M | 2012-05-01 – 2013-04-30 | evidence 0001157075-13-000010 |
| FY 2011 | $-1.9M | 2011-05-01 – 2012-04-30 | evidence 0001262463-12-000335 |
| FY 2010 | $-1.4M | 2010-05-01 – 2011-04-30 | evidence 0001262463-12-000335 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PHARMACYTE BIOTECH, INC. — all facts · Revenue · Operating Income